Ensaios clínicos de DPOC em Alabama
21 estudos para DPOC estão buscando participantes em locais em Alabama.
Cidades em Alabama
Texto oficial do estudo (Inglês)
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- University of Alabama at Birmingham, Birmingham
RecrutandoFase 2
Idades de 40 a 75 · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT07759245A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- University of Alabama at Birmingham - School of Medicine- Site Number : 8400003, Birmingham
RecrutandoFase 4
Idades de 40 a 85 · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- University of Alabama at Birmingham- Site Number : 8400003, Birmingham
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 15 de set. de 2026 · NCT07190222A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Birmingham
RecrutandoFase 2
Idades 40 e acima · Todos os sexos · Atualizado em 9 de set. de 2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- University of Alabama, Birmingham
RecrutandoFase 2
Idades 40 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Foley
- Research Site, Mobile
- Research Site, Sheffield
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Cullman
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06878261A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of Alabama at Birmingham, Birmingham
RecrutandoFase 1
Idades 18 e acima · Todos os sexos · Atualizado em 2 de set. de 2026 · NCT06603246A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- University of Alabama at Birmingham Lung Health Center, Birmingham
- SEC Clinical Research, Dothan
- Pulmonary Associates of Mobile, P.C., Mobile
RecrutandoFase 2/3
Idades de 35 a 80 · Todos os sexos · Atualizado em 31 de ago. de 2026 · NCT07363694A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Cullman
- Research Site, Mobile
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 26 de ago. de 2026 · NCT06283966A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 106, Birmingham
RecrutandoFase 3
Idades de 18 a 80 · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT07555483Improving Patient-Centered Care for Underserved Older African American Patients With Cardiovascular Comorbidities
- Cooper Green Mercy Hospital, Birmingham
RecrutandoEstudo observacional
Idades de 50 a 99 · Todos os sexos · Atualizado em 6 de ago. de 2026 · NCT07748858Multi-Center Clean Air Randomized Controlled Trial in COPD
- University of Alabama, Lung Health Center, Birmingham
RecrutandoFase 3
Idades 40 e acima · Todos os sexos · Atualizado em 31 de jul. de 2026 · NCT06376994Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the Hospital
- The University of Alabama at Birmingham, Birmingham
Recrutando
Idades 22 e acima · Todos os sexos · Atualizado em 23 de jun. de 2026 · NCT07222410SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Alabama at Birmingham, Birmingham
RecrutandoEstudo observacionalVoluntários saudáveis bem-vindos
Idades de 30 a 55 · Todos os sexos · Atualizado em 3 de jun. de 2026 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- University of Alabama-Birmingham Hospital - UAB Lung Health Center, Birmingham
Recrutando
Idades de 40 a 80 · Todos os sexos · Atualizado em 28 de abr. de 2026 · NCT07051707Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Alabama at Birmingham, Birmingham
Recrutando
Idades de 40 a 84 · Todos os sexos · Atualizado em 24 de abr. de 2026 · NCT06891755Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Sheffield
RecrutandoFase 3
Idades de 40 a 80 · Todos os sexos · Atualizado em 9 de abr. de 2026 · NCT06961214PiMZ Longitudinal Cohort (PiMZ Logic)
- University of Alabama at Birmingham, Birmingham
RecrutandoEstudo observacional
Idades 18 e acima · Todos os sexos · Atualizado em 16 de jan. de 2026 · NCT06505603Genetic Variation in IgG in Alpha 1 Antitrypsin Deficiency
- University of Alabama at Birmingham, Birmingham
RecrutandoFase 4
Idades 19 e acima · Todos os sexos · Atualizado em 10 de nov. de 2025 · NCT07135427myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- UAB School of Medicine/Lung Health Center, Birmingham
Recrutando
Idades 30 e acima · Todos os sexos · Atualizado em 6 de fev. de 2025 · NCT05204888Fonte: ClinicalTrials.gov, dados obtidos em 1 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.